Viewing Study NCT06004856

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2026-05-24 @ 2:25 PM
Study NCT ID: NCT06004856
Status: RECRUITING
Last Update Posted: 2024-05-13
First Post: 2023-08-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Primary Immune Thrombocytopenia (ITP) View
Keywords: